Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease

Nephrology

Volumn 17, Issue 2, 2012, Pages 104-110

  Abbiss, Hayley ^a,c,d   Maker, Garth L ^d   Gummer, Joel ^c   Sharman, Matthew J ^b   Phillips, Jacqueline K ^e   Boyce, Mary ^a   Trengove, Robert D ^c,d  

^a Schools of Natural Sciences ^*  (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

^c Separation Science and Metabolomics Laboratory   (Australia)

^d MURDOCH UNIVERSITY   (Australia)

^e MACQUARIE UNIVERSITY   (Australia)

Author keywords

biomarker; gas chromatography; metabolite; polycystic kidney disease; urine

Indexed keywords

2 OXOGLUTARIC ACID; ALLANTOIN; BIOLOGICAL MARKER; HIPPURIC ACID; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; URINALYSIS;

ALLANTOIN; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HIPPURATES; KETOGLUTARIC ACIDS; MALE; METABOLOMICS; PHENOTYPE; POLYCYSTIC KIDNEY DISEASES; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, INBRED LEW; URIC ACID; URINALYSIS;

EID: 84856151642     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01532.x     Document Type: Article

References (34)

1. Wishart DS,. Metabolomics: The principles and potential applications to transplantation. Am. J. Transplant. 2005; 5: 2814-20. (Pubitemid 43923941)
2. Ceglarek U, Leichtle A, Brugel M, et al,. Challenges and developments in tandem mass spectrometry based clinical metabolomics. Mol. Cell. Endocrinol. 2009; 301: 266-71.
3. A J, Trygg J, Gullberg J, et al,. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal. Chem. 2005; 77: 8086-94. (Pubitemid 43000566)
4. Vallejo M, García A, Tuñõn J, et al,. Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal. Bioanal. Chem. 2008; 394: 1517-24.
5. Zhang Q, Wang G, Du Y, Zhu L, A J,. GC/MS analysis of the rat urine for metabonomic research. J. Chromatogr. B 2007; 854: 20-25. (Pubitemid 46964844)
6. Ward CJ, Yuan D, Masyuk TV, et al,. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum. Mol. Genet. 2003; 12: 2703-10. (Pubitemid 37304692)
7. Sweeney WE, Avner ED,. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res. 2006; 326: 671-85. (Pubitemid 44786367)
8. Harris PC, Torres VE,. Polycystic kidney disease. Annu. Rev. Med. 2009; 60: 321-37.
9. Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O,. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 2006; 444: 949-52. (Pubitemid 46025010)
10. Simms RJ, Haynes AM, Eley L, Sayer J,. Nephronophthisis: A genetically diverse ciliopathy. Int. J. Nephrol. 2011; 2011: 1-10.
11. Menezes LFC, Onuchic LF,. Molecular and cellular pathogenesis of autosomal recessive polycystic kidney disease. Braz. J. Med. Biol. Res. 2006; 39: 1537-48. (Pubitemid 46357839)
12. Phillips JK, Hopwood D, Loxley RA, et al,. Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease. Kidney Blood Press. Res. 2007; 30: 129-44. (Pubitemid 46976031)
13. A J, Huang Q, Wang G, et al,. Global analysis of metabolites in rat and human urine based on gas chromatography/time-of-flight mass spectrometry. Anal. Biochem. 2008; 379: 20-26.
14. Taylor SL, Ganti S, Bukanov NO, et al,. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am. J. Physiol. Renal Physiol. 2010; 298: 909-22.
15. Toyohara T, Suzuki T, Akiyama Y, et al,. Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. Clin. Exp. Nephrol. 2011; 15: 676-87.
16. Alvarez-Sanchez B, Priego-Capote F, Luque de Castro MD,. Metabolomics analysis I. Selection of biological samples and practical aspects preceding sample preparation. Trends Analyt. Chem. 2010; 29: 111-19.
17. Alvarez-Sanchez B, Priego-Capote F, Luque de Castro MD,. Metabolomics analysis II. Preparation of biological samples prior to detection. Trends Analyt. Chem. 2010; 29: 120-27.
18. Walsh MC, Nugent A, Brennan L, Gibney MJ,. Understanding the metabolome-challenges for metabolomics. Nutr. Bull. 2008; 33: 316-23.
19. Giebisch G,. Kidney, water and electrolyte metabolism. Annu. Rev. Physiol. 1962; 24: 357-420.
20. 1H NMR-based metabonomic analysis of urine from young spontaneously hypertensive rats. J. Pharm. Biomed. Anal. 2008; 46: 550-56.
21. Holmes E, Loo RL, Stamler J, et al,. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008; 453: 396-400. (Pubitemid 351693125)
22. Whitehead TL, Monzavi-Karbassi B, Kieber-Emmons T,. 1H-NMR metabonomics analysis of sera differentiates between mammary tumor-bearing mice and healthy controls. Metabolomics 2005; 1: 269-78.
23. Whitfield PD, Noble PJM, Major H, et al,. Metabolomics as a diagnostic tool for hepatology: Validation in a naturally occurring canine model. Metabolomics 2005; 1: 215-25.
24. Liberator P, Anderson J, Feiglin M, et al,. Molecular cloning and functional expression of mannitol-1-phosphatase from the apicomplexan parasite Eimeria tenella. J. Biol. Chem. 1998; 273: 4237-44. (Pubitemid 28103296)
25. Forker EL,. Hepatocellular uptake of inulin, sucrose, and mannitol in rats. Am. J. Physiol. 1970; 219: 1568-73.
26. Schwiebert EM,. Compelling 'metabolomic' biomarkers may signal PKD Pathogenesis. Am. J. Physiol. Renal Physiol. 2010; 298: F1103-4.
27. Deguchi T, Takemoto M, Uehara N, Lindup WE, Suenaga A, Otagiri M,. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats. J. Pharmacol. Exp. Ther. 2005; 314: 932-38. (Pubitemid 41043880)
28. Alfazema LN, Howells S, Perrett D,. Determination of allantoin in biofluids using micellar electrokinetic capillary chromatography. J. Chromatogr. A 1998; 817: 345-52. (Pubitemid 28380216)
29. Forbes JM, Coughlan MT, Cooper ME,. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008; 57: 1446-54.
30. Schwiebert EM, Wallace DP, Braunstein GM, et al,. Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am. J. Physiol. Renal Physiol. 2002; 282: F763-75. (Pubitemid 34654524)
31. Wilson PD, Hovater JS, Casey CC, Fortenberry JA, Schwiebert EM,. ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys. J. Am. Soc. Nephrol. 1999; 10: 218-29. (Pubitemid 29068060)
32. Bando K, Kawahara R, Kunimatsu T, et al,. Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. J. Biosci. Bioeng. 2010; 110: 491-99.
33. Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD,. Analytical and statistical appraoches to metabolomics research. J. Sep. Sci. 2009; 32: 2183-99.
34. Kind T, Tolstikov V, Fiehn O, Weiss RH,. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal. Biochem. 2007; 363: 185-95. (Pubitemid 46428214)